Chinese central bank conducts USD280.35M worth of seven-day reverse repos


(MENAFN) China's central bank, on Thursday, undertook a significant monetary operation by conducting 2 billion yuan (approximately 280.35 million U.S. dollars) worth of seven-day reverse repurchase agreements (repos) at an interest rate of 1.8 percent. This strategic move by the People's bank of China (PBOC) is aimed at maintaining reasonable and sufficient liquidity within the banking system, according to statements from the central bank.

In financial terms, a reverse repo involves the central bank purchasing securities from commercial banks through a competitive bidding process, with a commitment to sell them back at a later date. This mechanism allows the PBOC to inject liquidity into the financial markets temporarily, ensuring that banks have adequate funds to meet their short-term funding needs.

The decision to conduct this reverse repo operation underscores the PBOC's ongoing efforts to manage monetary policy effectively, balancing the need for liquidity support with measures to control inflation and stabilize economic growth. By providing liquidity through such operations, the central bank aims to foster stable financial conditions and support ongoing economic activities across various sectors.

These monetary operations are part of broader strategies employed by the PBOC to fine-tune liquidity conditions in response to evolving economic dynamics and external pressures. The effectiveness of such measures is closely monitored to ensure they align with the central bank's objectives of promoting sustainable economic development while safeguarding financial stability in China.

MENAFN11072024000045015839ID1108430903


MENAFN

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.